Medicare Enrolled

Dr. Robert Schiftan, MD

Neurology · Boca Raton, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1905 CLINT MOORE ROAD, Boca Raton, FL 33496
5619818011
In practice since 2007 (19 years)
NPI: 1215063839 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schiftan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schiftan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schiftan

Dr. Robert Schiftan is a neurology in Boca Raton, FL, with 19 years in practice. Based on federal Medicare data, Dr. Schiftan performed 210 Medicare services across 137 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schiftan received a total of $3,362 from 24 pharmaceutical and/or device companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schiftan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 210 Medicare services$ $3,362 industry payments

Medicare Practice Summary

Medicare Utilization ↗
210
Medicare services
Bottom 26% in FL for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
137
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~11 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity82$86$110
Initial hospital admission, high complexity68$142$215
Office visit, established patient (20-29 min)44$70$311
Measurement of brain wave activity (eeg), awake and drowsy16$45$61
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,362
Total received (2018-2024)
Avg $480/year across 7 years
Top 43% in FL for neurology
24
Companies
69
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,362 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$376
2023
$540
2022
$462
2021
$896
2020
$241
2019
$329
2018
$517

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ACADIA Pharmaceuticals Inc
$917
AstraZeneca Pharmaceuticals LP
$280
Amgen Inc.
$278
E.R. Squibb & Sons, L.L.C.
$246
Amneal Pharmaceuticals LLC
$241
ABBVIE INC.
$164
AbbVie Inc.
$155
Lilly USA, LLC
$151
Janssen Pharmaceuticals, Inc
$138
Silk Road Medical, Inc.
$123
HARMONY BIOSCIENCES LLC
$117
Kyowa Kirin, Inc.
$83
MDD US Operations, LLC
$60
ARGENX US, INC.
$56
Allergan Inc.
$47
Ceribell, Inc.
$46
US WorldMeds, LLC
$46
Novartis Pharmaceuticals Corporation
$45
Teva Pharmaceuticals USA, Inc.
$41
Biohaven Pharmaceutical Holding Company Ltd.
$39
Biogen, Inc.
$37
Neurelis, Inc.
$18
Eisai Inc.
$17
Allergan, Inc.
$17
Top 3 companies account for 43.9% of total payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · ANDEXXA · APOKYN · AVONEX · Aduhelm · Aimovig · BOTOX THERAPEUTIC · BRILINTA · EMGALITY · ENROUTE Transcarotid Neuroprotection System · GILENYA · GOCOVRI · INVOKANA · KISUNLA · NOURIANZ · NUPLAZID · NURTEC ODT · POCKET EEG DEVICE · QULIPTA · RYTARY · UBRELVY · VALTOCO · VYVGART HYTRULO · Wakix · XARELTO · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,601 per 100 Medicare services performed
Looking for a neurology in Boca Raton?
Compare neurologys in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
149
Per 100K population
9.9
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
3.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Schiftan is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Schiftan experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Schiftan performed 82 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schiftan receive payments from pharmaceutical companies?
Yes. Dr. Schiftan received a total of $3,362 from 24 companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schiftan's costs compare to other neurologys in Boca Raton?
Dr. Schiftan's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schiftan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →